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Abstract: A novel nanomagnetic catalyst with Cl[DABCO-NOR2R]C(NOR2R)R3R tags was designed, 
synthesized and fully characterized by several identical techniques such as Fourier transform 
spectroscopy infrared (FT-IR), Energy-dispersive X-ray spectroscopy (EDX), elemental mapping 
analysis, thermal gravimetry analysis (TG), derivative thermal gravimetric (DTG), powder X-ray 
diffraction patterns (XRD), Field scanning electron microscopy (FESEM), high resolution 
transmission electron microscopy (HRTEM), physical adsorption and physisorption of NR2R 
isotherms (BET) and vibrating sample magnetometer (VSM). The mentioned nano-magnetic 
particles were used as an efficient and recyclable catalyst for the one-pot three component 
condensation reaction of 5-amino-3- methyl-1-phenylpyrazole, aryl aldehydes and malononitrile 
for the synthesis of pyrazolo[3,4-b]-pyridine derivatives under neat condition. 
Introduction 
Nowadays, chemical processes that produce the least waste and pollutants are paramount 
important. One of the ways to achieve this great goal is to use catalysts. Catalysts increase 
chemical reactions rate by reducing the corresponding activation energy, which reduces energy 
consumption [1]. Homogeneous catalysts have a good performance in chemical processes, but 
their separation from the reaction mixture is tediously long, so the use of heterogeneous catalysts 
is replaced [2]. In order to increase the efficiency of heterogeneous catalysts, they can be designed 
in nano dimensions [3, 4]. But nano-sized catalysts cannot be separated by conventional filtration 
techniques. Then, nano-magnetic catalysts are designed to solve the mentioned problem. 
Generally, these catalysts can be easily separated by using an usual external magnetic field from 
the reaction and reused several times with only a marginal decrease in reactivity [5,6]. 
In order to increase the efficiency of chemical reactions, simplify the process, saving time and 
energy, increasing the atomic economy, reducing use of organic solvents and waste generation, 
multi-component reactions (MCRs) are introduced. Therefore, the intention of MCRs is 
important in the synthetic organic methodologies [7,8].  
The anomeric effect is one of the most important fundamental factors which are influencing the 
reactivity of susceptible systems. This concept has been extensively reviewed to discuss the 
origin, magnitude, scope and limitations of this important phenomenon in various systems [9-12].  
Anomeric effect is considered for justifying some observations in chemistry. This phenomenon, 
which is caused by the interaction between the lone pair electrons of the heteroatoms and the 
antibonding orbital of the adjacent bonds, can affect the pathway of the reaction mechanism, 
causing the abnormal hydride transfer following releasing of a hydrogen gas. Recently, a new 
terminology entitled "anomeric based oxidation (ABO)" has been introduced for driving force of 
aromatization in susceptible heterocyclic compounds which have heteroatoms at the appropriate 
sites. Other than experimental observations, computational evidence also confirms this 
mechanism [13]. 
The systematic study of the anomeric effect in target molecules, allows for the design of 
synthetic strategies based on anomerically driven stereoselective reactions, or highly biased 
equilibria among isomeric products. To the best of our knowledge, many biological processes 
involve oxidation-reduction of substrates by NAD+/NADH and/or NADP+/NADPH respectively 
(Figure 1). The key feature of the oxidation mechanism in these systems is hydride transfering 
from carbon to substrates via anomeric based oxidation. Thus, development of anomeric based 
oxidation and/or aromatization mechanism lead to knowledge based designing of biomimetic 
reactions in the future. We think that the obtained results from this field of research will be 
support the idea of rational designs, syntheses and applications of tasked-specific catalysts and 
molecules for the development of anomeric based oxidation and/or aromatization mechanism [14-
17]. 
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Figure 1. Molecular structures of NADH and NADPH 
Pyrazole derivatives have attracted great interest due to the variety of biological and 
pharmacological activities such as antiviral P[18]P, antidiabetic, P[19]P, hypotensive P[20]P, anticancer P[21]P 
antitumor, antibacterial P[22]P and anti-inflammatory P[23]P. These compounds also can be effective in 
the remedy of gastrointestinal disease, drug and alcohol withdrawal symptoms, anorexia nervosa 
depression, hemorrhaged stress, Alzheimer’s disease, infertility and drug addiction P[24, 25]P. It has 
recently been found that pyrazolo[3,4-b]-pyridines can be also used as FGFR Kinase 
Inhibitors P[26]P and metabotropic glutamate receptor 5 (mGluR5) P[27]P (Figure 2). Therefore, due to 
these important biological abilities, any development in the synthetic organic methodology for 
preparation of these compounds is great demanded. 
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Figure 2. (a) FGFR Kinase Inhibitors (b) metabotropic glutamate receptor 5 (mGluR5) 
With this aim, we wish to introduce Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3 as a novel 
nanomagnetic catalyst and use it as an efficient and reusable catalyst in the synthesis of 
pyrazolo[3,4-b]-pyridine derivatives via anomeric based oxidation under solvent-free condition 
(Scheme 1).  
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Scheme 1. MCRs Synthesis of pyrazolo[3,4-b]-pyridine derivatives using FeR2ROR3R@SiOR2R(CHR2R)R3R-Cl[DABCO-
NOR2R]C(NOR2R)R3R as novel nano magneticR Rcatalyst under solvent free conditions. 
 
The outlook of chemical processes is moving towards the goal of sustainable development. With 
this aim, the design, synthesis and applications of “benign” catalysts have been one of the serious 
challenges for chemists and chemical engineers since many years ago. Due to the important role 
of catalysts in chemical processes, design, synthesis and application of new catalysts are great 
attracted. Among of catalysts, nano magnetic catalysts have attracted much attention due to their 
efficient properties such as reusability, easy separation and eco-friendly nature. So, 
FeR2ROR3R@SiOR2R(CHR2R)R3R-Cl[DABCO-NOR2R]C(NOR2R)R3R was designed, synthesized and fully 
characterized by identification techniques. This novel nano magnetic catalyst was used in the 
synthesis of pyridine derivatives as biological and pharmaceutical candidate drugs.  
Results and discussion 
Synthesis and Characterization of the novel nano magnetic catalyst 
Our strategy for the synthesis of magnetic nanoparticles functionalized DABCO double ionic 
liquids tags (Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3) has been shown in Scheme 2. 
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Scheme 2. Synthetic route for Synthesis of novel nano magnetic catalyst Fe2O3@SiO2(CH2)3-Cl[DABCO-
NO2]C(NO2)3. 
 
As shown in Scheme 2, the DABCO double ionic liquids tags functionalization of magnetic 
nanoparticles (MNPs) can be achieved in a four step process. First of all, synthesis of core/shell 
Fe2O3@SiO2 was done by known method based on the literature with some modification (II). 
Moreover, functionalization of magnetic nano particles with silylpropylchloride linker was done 
by using 3-chloropropyltrimethoxysilane (III). Then, DABCO as a double head tertiary amine 
ligand was entered to the magnetic nanoparticles by reflux in toluene (III) and through this way, 
the first ionic liquids tags was presented. Finally, DABCO-functionalized magnetic nanoparticles 
(IV) were reacted with C(NO2)4 to transfer one of the acidic NO2 groups and coordinated to the 
second amine of DABCO (V). 
 
For confirmation the successful synthesis of the catalyst, the structure of the novel nano 
magnetic heterogeneous catalyst was fully characterized by various techniques such as Fourier 
transform spectroscopy infrared (FT-IR), elementals mapping survey with energy-dispersive X-
ray spectroscopy (EDX), thermal gravimetry analysis (TGA), derivative thermal gravimetric 
(DTG), powder X-ray diffraction patterns (XRD), Field scanning electron microscopy (FESEM), 
high resolution transmission electron microscopy (HRTEM), Physical adsorption and 
physisorption of N2 isotherms (BET) and vibrating sample magnetometer (VSM). 
 
The FT-IR spectrum of the novel nano magnetic catalyst and its comparison with starting 
materials is presented in Figure 3. As shown in Figure 3, the peak observed at 586 cm-1 is related 
to the formation of magnetic nanoparticles which is attributed to the Fe-O bonds. The depicted 
sharp and broad band at 1076 is related to Si-O-Si stretching in silica layer. the absorption bond 
at 1384 cm-1 and 1629 cm-1 is connected to the vibrational modes of the -NO2 bonds. Also, the 
peak that recognized at 1715 cm-1 has been disappeared in Fe2O3@SiO2(CH2)3-Cl[DABCO] 
catalyst (Figure 3). 
 
  
Figure 3. The FT-IR spectrum of a) Fe2O3@SiO2(CH2)3-Cl[DABCO], and b) Fe2O3@SiO2(CH2)3-Cl[DABCO-
NO2]C(NO2)3. 
Next, the Energy-dispersive X-ray spectroscopy (EDX) and elemental mapping analysis were 
used to prove the organic content and also the existence of elemental composition of the 
MNPs, which could be explained by the DABO ionic liquid tags attache to the MNPs 
(Figures 4a-h). As shown, the results confirmed the presence of carbon (C: 23.73%), 
nitrogen (N: 12.70%), oxygen (O: 48.33%), Chloride (Cl: 0.06%), Iron (Fe: 11.63%) and 
Silisum (Si: 3.56%), as the expected elements in the catalyst structure. morover, the 
selected‐ area elemental analysis displays the regular uniformity of the synthesized MNPs.      
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Figure 4. a)The EDX spectroscopy quantitative; b) total elemental maps and displays of C (c), N (d), O (e), Si 
(f), Fe (g), and Cl (h) atoms in the MNPs of  catalyst.   
 
 
To investigate the morphology, topography and resolve the interior of the structures in the 
final catalyst, high-resolution transmission electron microscopy (HRTEM) and Field 
emission scanning electron microscopy (FESEM) were carried out as shown in (Figure 5). 
As it is clear in the figure a,b, with presents of SiO2 layers to disorganized and uneven 
Fe2O3 in the first stage and then cordination with propeyl linker in the final steps with 
DABCO dobel head ionic tags, the shape of Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3 
were seperated, arranged and improved to a symmetrical doble spherical MNPs. As shown in 
Figure 5b, the crystal Fe2O3-MNPs distance layer of final nanoparticles of catalyst are 
around 0.26 nm which has good correlation with the plane layer (311) in sharpest peak at the 
powder XRD results. Moreover, the FESEM results clearly aproved the spherical uniform of 
the MNPs in the sample (Figure 5c). 
 
 Figure 5. a) High resolution transmission electron microscopy (HRTEM) images of a) Fe2O3@SiO2(CH2)3-
Cl[DABCO-NO2]C(NO2)3 in 5nm scale; inlet: b) 2nm selected scale area (V); and c) field emission scanning 
electron microscopy (FESEM) of final catalyst nanoparticles in 100nm scale. 
 
(a) (b) 
 
(c) 
Thermogravimetric (TG) analysis, derivatives thermal gravimetric analysis (DTG), and the 
differential thermal analysis (DSC) were performed to analyze the content of DABCO ionic 
tags in catalysts under argon atmosphere (Figure 6). From the performed studies, it may be 
inferred that the two main weight loss upon heating, first, from ambient temperature to 110 
ºC with weight loss of ~ 1 wt% could be related to the removal of surface-adsorbed water 
and organic solvents applied during the catalyst preparation and the second part from 200 ºC 
to 300 ºC with weight loss of  >11 wt% could be reasoned for the ionic molten salt nature of 
DABCO with diferrent NO2 parts. Moreover, from analysis diagram from the results of DSC 
in figure 6b, the catalysts has shown three different thermal behaveriuos. in the firs stage, it 
has shown downward and exotemic pattern from 25 ºC to 110 ºC, in the second and main part 
of catalyst, from 110 ºC to ~ 400 ºC it has shown a upwards with endothrmic pattern and 
finally, in the last part from ~ 400 ºC to 800 ºC it has shown again a downward behaviour  
with endothermic maner. 
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 Figure 6. a) Thermal gravimetric analysis (TG/DTG), and b) (TGA/DSC) of MNPs. 
 
Further observations were made by Powder X-ray diffraction (XRD) to illustrate the crystalline 
structure of MNPs in a range of 10 < 2θ < 90° (Figure 7). The upward typical iron oxide 
spectrum pattern was showed peaks at 2θ values of 14.96°, 18.38°, 30.24°, 35.63°, 43.28°, 
53.73°, 57.27°, 62.93° and 74.47° related to (110), (111), (220) (311), (400), (422), (511), (440)  
and (533) corresponding to planes of iron oxide (FexOy). Moreover, as clear from the 
Maghemite (Fe2O3) with blue standard lines (JCP2: 00-039-1346) and magnetie (Fe3O4) with 
red standard lines (JCP2: 01-075-1609) as the standard references, the center of each peaks may 
be adjusted with maghemite (Fe2O3) structures more than magnetie (Fe3O4). Also the sharpest 
peak in XRD spectrum of the catalyst has been correlated to plane (311) at 30.24º with 2.51Å 
layer distance and the largest layer distance are connected to layer (220) at 30.24º with 2.95 Å. 
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 Figure 7. powder XRD pattern of MNPs, inlet blue solid lines: JCP2: 00-039-1346 for standard data base of 
Fe2O3 and inlet red solid lines: (JCP2: 01-075-1609) for standard data base of Fe3O4 
In continuation investigation of catalyst, N2 adsorption/desorption isotherm was performed 
to characterize the porosity and total surface area of the magnetic nanoparticles. As shown in 
Figure 8a, catalyst exhibited type II isotherm according to the IUPAC definition and with H3 
type hysteresis loop, which displaied the presence of a nanoporous structure. The surface 
area and pore volume of the catalyst are listed in Table 2. The determined Brunauer-Emmett-
Teller (BET), BJH and DR specific surface areas of Fe2O3@SiO2(CH2)3-Cl[DABCO-
NO2]C(NO2)3 are 112.766, 61.676 and 108.923 m2g-1 respectively. Moreover, the total pore 
volume was achived 0.31 cm3g-1. the corresponding pore-size distribution (PSD) of 
nanopores (inset of Figures 10b) was calculated from the adsorption branch on the basis of 
BJH model (Figure 8b) and is centered at 15 nm, according to the (BJH) model. 
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 Figure 8 a) Nitrogen adsorption/desorption isotherms and b) inset: BJH pore size distribution of 
Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3 
Table 1. Textural properties of Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3 
SBETa 
(m2g-1) 
SBJHb 
(m2g-1) 
Smc 
(m2g-1) 
Vtd 
(cm3g-1) 
pore sizee 
 
(nm) 
112.766 61.676 108.923 0.31 14.826 
a SBET: total surface area. b SBJH: surface area estimated by BJH model applied to the desorption branch of the 
isotherm. c Sm: Micropore surface area estimated by DR model . d V t: total pore volume. e Obtained from BJH. 
 
The magnetic measurement of Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3 was also 
studied. Its VSM was compared with its precursors Fe2O3, Fe2O3@SiO2 and 
Fe2O3@SiO2(CH2)3Cl. As shown in Figure 9, after adding of each layer, the saturation 
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magnetization reduces from 70.55 emu g−1 for Fe2O3 to 50.01 emu g−1 for describe 
Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3. 
 
Figure 9. VSM magnetization curves of catalyst was compared with its precursors Fe2O3, Fe2O3@SiO2, 
Fe2O3@SiO2(CH2)3Cl, nano particles 
After fully Characterization and investigation  of  Fe2O3@SiO2(CH2)3-Cl[DABCO-
NO2]C(NO2)3 structure, it was used as nano magnetic catalyst in the condensation reaction of 3-
methyl-1-phenyl-1H-pyrazol-5-amine, malnonitrile and various aromatic aldehydes for the 
synthesis of pyrazolo[3,4-b]-pyridine derivatives. For this aim, at first to optimize the reaction 
conditions, the reaction of benzaldehyde, 3-methyl-1-phenyl-1H-pyrazol-5-amine and 
malononitrile was selected as model reaction. The results for the optimization of temperatures, 
catalyst amount and solvents are summarized in Table 2. As shown in Table 2, the best results 
for the synthesis of pyrazolo[3,4-b]-pyridines were achieved when the reaction curried out at 100 
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°C in the presence of 5 mg Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3 under solvent free 
conditions. 
Table 2. The reaction of  benzaldehyde, 3-methyl-1-phenyl-1H-pyrazol-5-amine and malononitrile under different 
conditions.a 
H
O
(5 mg), 
 neat,  100 °C
Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3
++ NC CN
N
CN
NH2
N
N
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aReaction conditions: aryl aldehyde (1 mmol), malononitrile (1.2 mmol, 79 mg), 3-methyl-1-phenyl-1H-pyrazol-5-
amine (1 mmol, 173 mg) and [Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3] (5 mg). bIsolated yield. 
After optimizing the reaction conditions, to assess the scope and limitations of the catalyst, 3-
methyl-1-phenyl-1H-pyrazol-5-amine was reacted with various aromatic aldehydes (bearing 
electron releasing and electron-withdrawing groups) and malononitrile. As shown in Table 3, the 
results indicate that this method is appropriate for the synthesis of pyrazolo[3,4-b]-pyridine 
derivatives.  
Table 3. Synthesis of pyrazolo[3,4-b]-pyridine derivatives using Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3 
as a new nanomagnetic catalyst under solvent free conditions.a 
Entry Solvent Load of Catalyst (mg) Temp. (°C) Time (min) Yield (%)b 
1 - 10 80 30 81 
2 - 10 100 25 89 
3 - 10 110 25 89 
4 - 8 100 25 89 
5 - 5 100 25 89 
6 - 3 100 40 75 
7 EtOH 5 Reflux 240 35 
8 EtOAc 5 Reflux 180 32 
9 H2O 5 Reflux 240 Trace 
10 CH3CN 5 Reflux 180 38 
HO
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time: 35 min; yield: 92%; 
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time: 20 min; yield: 91%; 
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time: 30 min; yield: 91%; 
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time: 30 min; yield: 93%; 
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time: 20 min; yield: 88%; 
Mp: 214-216 °C [20] 
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 time: 20 min; yield: 85%; 
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time: 35 min; yield: 85%; 
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time: 30 min; yield: 90%; 
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time: 25 min; yield: 87%; 
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Mp: 203-205 °C 
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time: 25 min; yield: 93%;  
Mp: 237-239 °C 
aReaction conditions: aryl aldehyde (1 mmol), malononitrile (1.2 mmol, 79 mg), 3-methyl-1-phenyl-1H-
pyrazol-5-amine (1 mmol, 173 mg) and [Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3] (5 mg). b All yields 
are isolated yields. 
 
The recovery and reusing of Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3 were investigated 
under optimized conditions for the reaction of benzaldehyde, 3-methyl-1-phenyl-1H-pyrazol-5-
amine and malononitrile. In these conditions, the nano magnetic catalyst was reused up to nine 
times with only a marginal decrease in its reactivity. After each use, in order to separation of the 
catalyst, the reaction mixture was dissolved in acetone. Then, the catalyst was extracted by using 
an external magnet and reused in the subsequent reactions after washing. As shown in Figure 10, 
activity of this catalyst is maintained up to nine times without any significant changes in the 
yields and reaction times. 
 Figure 10. the reaction of benzaldehyde, 3-methyl-1-phenyl-1H-pyrazol-5-amine and malononitrile using 
recycled nano magnetic catalyst. 
According to previously reported methods [20,23], an applicable mechanism for the synthesis of 
pyrazolo[3,4-b]-pyridines is proposed. In the beginning, malononitrile reacts with aldehyde 
which is activated by Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3 to affords cyanoolefin 2 
by removing one molecule of HNO3 [28]. Then, 3-methyl-1-phenyl-1H-pyrazol-5-amine attacks 
to the intermediate 2 as a Michael acceptor to gives 3. Next, cyclization of 3 creates intermediate 
4 which is converting to desired product via hyperconjugative-like anomeric based oxidation 
(Scheme 3). Previously reported studied have proposed an aerobic oxidation of intermediate 5 to 
target molecule 7. In contrast to the previously reported mechanistic route [23] for the final step of 
the aforementioned described organic synthesis, we suggested that, this step might be proceeded 
via unusual hydride transfer as well as Cannizzaro reaction (Scheme 4) [29] pyranose acatals 
(Scheme 5) [30] and H2 releasing from tricyclic orthoamide (Scheme 6) [31]. As presented in 
Scheme 7, isomer with equatorial 2-methoxy group is more reactive than its axial isomer due to 
two lone pair anomeric assistance to the departure of the hydride leaving group.[30]  
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Scheme 3. The proposed mechanism for the synthesis of pyrazolo[3,4-b]-pyridines in the presence of 
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Scheme 4. The suggested mechanism for the in-situ oxidation-reduction in Cannizzaro reaction by uncommon 
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Scheme 5. An excellent example which had been reported for an unusual hydride transfer from 2-methoxypyranose 
by ABO mechanism.[30] 
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Scheme 6. A striking example which had been detected for an unusual hydride transfer from tricyclic orthoamide 
(A) by ABO mechanism. [31] 
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Scheme 7. Isomer with equatorial 2-methoxy group is more reactive than its axial isomer due to two lone pair 
anomeric assistance to the departure of the hydride leaving group [30]. 
As above mentioned, we have introduced an "anomeric based oxidation (ABO)" terminology for 
the final step in mechanistic route in the synthesis of various molecules such as: 1,4-
dihydropyrano-[2,3-c]-pyrazoles [32], 2,4,6-triarylpyridines [33], 2-amino-3-cyanopyridines [34], 2-
sbstituted benz-(imida, oxa and othia)-zole derivatives [28], oxidative aromatization of 
pyrazolines and 1,4-dihydropyridines [35], sulfanylpyridines [36], and 2-amino-4-aryl-6-
(arylamino)pyridine-3,5-dicarbonitriles [37]. For approving the aforementioned idea, reaction was 
carried out under both nitrogen and argon atmosphere and in the absence of any molecular 
oxygen. It was found that, the reaction progressed under atmosphere of nitrogen and argon 
slightly slower than normal reaction condition (air atmosphere). On the basis of the above-
mentioned evidence, conversion of intermediate 3 to target molecule 4 might be occurred by 
unusual hydride transfer and releasing of molecular hydrogen (H2). The C–H bond is weakened 
via hyper conjugation-like of the nitrogen lone pairs into the anti-bonding of C-H (σ*C-H 
orbital) which can be broken by reaction with a proton to give molecular hydrogen. 
Conclusions  
In summary, magnetic nanoparticles (MNPs) surface were chemically modified with 
Cl[DABCO-NO2]C(NO2)3 tags and Fe2O3@SiO2(CH2)3-Cl[DABCO-NO2]C(NO2)3 was 
designed, synthesized and fully characterized by several techniques such as FT-IR, 
EDX/mapping, FESEM, HRTEM, TGA, DTG, DSC, powder XRD, N2 adsorption (BET) and 
VSM. The described nano magnetic particle was used as an efficient catalyst for the three-
component condensation reaction of aryl aldehydes, 3-methyl-1-phenyl-1H-pyrazol-5-amine and 
malononitrile under solvent free conditions. Short reaction times, good yields and easy work-up, 
reusability of catalyst, and solvent free condition are major advantages of this work. Also, in the 
possible mechanism, an anomeric based oxidation was suggested for the final step of 
pyrazolo[3,4-b]-pyridines synthesis. 
Experimental 
In continuation of our researches on the exploring of new nano magnetic catalysts [38], herein, we 
designed and synthesized the nano magnetic particles named Fe2O3@SiO2(CH2)3-Cl[DABCO-
NO2]C(NO2)3. The mentioned nano particles were applied as an efficient and reusable catalyst 
in the synthesis of pyrazolo[3,4-b]-pyridines via anomeric based oxidation under solvent free 
conditions. 
 
General 
All chemicals were obtained from Merck, Sigma Aldrich and used without further purification. 
The known products have been identified by comparison of their melting points and spectral data 
with those reported in the literature. Progress of the reactions was monitored by TLC using silica 
gel SIL G/UV 254 plates. Melting points were recorded on a Büchi B-545 apparatus in open 
capillary tubes. Rf values were measured using EtOAc: n-Hexane (3:7) as elution solvents. 
Fourier transformed infrared (FTIR) spectra of the catalyst and the synthesized products were 
performed on a FTIR spectrometer Perkin-Elmer spectrum 65 using KBr disks. High resolution 
mass spectra (GC/QTOF, Chemical Ionization (CI) mode with 20% CH4 and 300 °C source 
temperature) were obtained using an Agilent 7200 Network spectrometer. Each sample was 
dissolved in CHCl3 and directly injected to the instrument by using standard Agilent glass 
capillary. 1H NMR (300 and 400 MHz) spectra were obtained on a Bruker Avance 300 and a 
Bruker Avance 400 NMR spectrometers under proton coupled mode using CDCl3 as solvent. 13C 
NMR (75, 101 and 126 MHz) spectra were acquired on a Bruker Avance 300,  a Bruker Avance 
400 NMR and Bruker Avance DRX 500 NMR spectrometer in the proton decoupled mode at 20 
°C in CDCl3 as solvent. Chemical shifts are given in δ (parts per million) and the coupling 
constants (J) in Hertz. 19F NMR (282 and 376 MHz) spectra were recorded on a Bruker Avance 
300 and a Bruker Avance 400 NMR spectrometer, in proton coupled mode. Data for 1H NMR 
spectra is reported as follows: chemical shift (ppm), multiplicity (s, singlet; d, doublet; t, triplet; 
q, quartet; m, multiplet; and br., broad), coupling constant (Hz), and integration. Simultaneous 
thermal gravimetry analysis TG-DSC, were carried out on a Mettler Toledo equipment (model 
TGA/SDTA851and/LF/1600), capable of working between room temperature and 1600 °C under 
inert Argon atmosphere and  is equipped with a 34 position autosampler. The experiment was 
carried out at 25°C and using a heating rate of 25 °C min-1 up to 800 °C. Powder X-ray 
diffraction (XRD) pattern was recorded with a Bruker D8-Advance with mirror Goebel (non-
planar samples), high temperature Chamber (up to 900°C), generator of x-ray 
KRISTALLOFLEX K 760-80F (power: 3000W, voltage: 20-60KV and current: 5-80 mA) and 
with a tube of RX with copper anode Kα (λ = 0.154 nm) in the range 10° < 2θ < 90°. Physical 
adsorption and physisorption of N2 isotherms were measured at 77 K with an AUTOSORB-iQ-
XR-2 analyzer. The catalyst was degasses before the experiment for one day at 100 °C under 
high vacuum condition. The Brunauer-Emmett-Teller (BET) method was used to calculate the 
specific surface areas (SBET). By using the Barrett-Joyner-Halenda (BJH) model, the pore 
volumes and pore size distributions were derived from the adsorption branches of isotherms. The 
micropore surface area (SBET micro) was calculated using the V-t plot method. Scanning electron 
microscopy (SEM) studies were performed using a Hitachi S3000N, equipped with an X-ray 
detector Bruker XFlash 3001 for microanalysis (EDX) and elemental mapping. Field emission 
scanning electron microscopy (FESEM) studies were performed using a Merlin VP Compact 
from Zeiss, equipped with an EDS microanalysis system Quantax 400 from Bruker. The 
resolution is 0.8 nm at 15 kV and 1.6 nm at 1 kV. Field emission equipment is able to work at 
voltages very reduced (from 0.02 kV to 30 kV) allowing to observe beam sensitive samples 
without damaging them and minimizing the charging effects. High-resolution transmission 
electron microscopy (HRTEM) images were obtained using a JEOL JEM-2010 microscope 
operating at an accelerating voltage of 200 kv. This microscope is equipped with an X-ray 
detector OXFORD INCA Energy TEM 100 for microanalysis (EDS) and acquisition of the 
images is made by means of a digital camera GATAN ORIUS SC600 mounted on-axis, 
integrated with the program GATAN DigitalMicrograph 1.80.70 for GMS 1.8.0. Sample was 
prepared by drop casting the dispersed particles in absolute ethanol onto a 300-mesh copper grid 
from TED PELLA, INC. model 01883-F, coated with a lacey formvar film enforced by a heavy 
coating of carbon. Holes are completely open. The magnetic behavior of the nano magnetic 
catalyst was also measured by a vibrating sample magnetometer (VSM) instrument from 
Meghnatis Daghigh Kavir Company model LBKFB. 
 General procedure for the preparation of the novel nanomagnetic catalyst 
Fe2O3 nanoparticles were prepared according to the previously reported procedure. Then, 1 g of 
Fe2O3 nanoparticles (I) was dispersed in toluene. In the next step, to coat the surface of the 
Fe2O3 with SiO2, 1.5 mL tetraethyl orthosilicate (TEOS) was added drop-wise and the reaction 
was continued for 12 h under reflux conditions. The resultant Fe2O3@SiO2 (II) was washed with 
ethanol for three times and dried. After that, in order to silanate the silica coated nanomagnetic 
particles, 3-chloropropyltrimethoxysilane (1.5 mL) was added to the mixture in toluene under 
reflux conditions to give (III). After 12 h, compound (III) was washed with ethanol, then 1,4-
diazabicyclo[2.2.2]octane (DABCO) (6 mmol, 0.67 g) was added and refluxed in ethanol for 12 
h to afford compound (IV). Eventually, tetranitromethane (6 mmol, 1.18 g, 0.73 mL) was added 
to compound (IV) in toluene under reflux conditions to give (V) as a novel nano magnetic 
catalyst (Scheme 2). 
 
General procedure for the synthesis of pyrazolo[3,4-b]-pyridine derivatives 
To a round-bottom flask containing a mixture of aldehydes (1mmol), 3-methyl-1-phenyl-1H-
pyrazol-5-amine (1 mmol, 173 mg) and malnonitrile (1.2 mmol, 79 mg) 5 mg 
FeR2ROR3R@SiOR2R(CHR2R)R3R-Cl[DABCO-NOR2R]C(NOR2R)R3R was added. The resulting mixture was stirred 
magnetically under solvent-free conditions at 100 °C. After completion of the reaction which 
was monitored by TLC, the mixture was cooled to room temperature. Then, acetone was added 
to separate the catalyst by an external magnet. After evaporation of the solvent, the resulting 
solid was recrystallized in ethanol to give pure products. Finally, the nanomagnetic catalyst was 
reused for the next run (Scheme 1). 
Results spectral data of products: 
6-amino-3-methyl-1,4-diphenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile (1a): 
Isolated as white solid, (290 mg, 89%), RRfR: 0.52, Melting point: 210 – 212 °C; FT-IR: υ (cmP-1 P) = 
3366, 3219, 2217, 1626, 756; P1 PH NMR (300 MHz) δ 8.11 (dd, J = 8.6, 1.1 Hz, 2H), 7.66 – 7.39 
(m, 7H), 7.35 – 7.27 (m, 1H), 5.42 (br. s, 2H), 2.03 (s, 3H). P13PC NMR (101 MHz) δ 158.3, 152.8, 
150.9, 144.4, 138.8, 134.0, 129.9, 129.0, 128.6 (2c), 126.2, 121.5, 116.8, 109.5, 88.5, 14.7; 
HRMS calcd. for CR20RHR15RNR5R [MP+P] 325.1327, found. 325.1343. 
6-amino-4-(3,4-dimethoxyphenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-
carbonitrile (1b) 
Isolated as white solid, (354 mg, 92%), RRfR: 0.35, Melting point: 218 – 220 °C; FT-IR: υ (cmP-1 P) = 
3332, 3222, 2210, 1626, 765; P1 PH NMR (300 MHz) δ 8.10 (dd, J = 8.6, 1.1 Hz, 2H), 7.58 – 7.42 
(m, 2H), 7.35 – 7.27 (m, 1H), 7.11 – 7.00 (m, 2H), 6.98 (d, J = 1.5 Hz, 1H), 5.41 (br. s, 2H), 3.98 
(s, 3H), 3.94 (s, 3H), 2.13 (s, 3H). 13C NMR (101 MHz) δ 158.4, 152.7, 150.9, 150.3, 148.8, 
144.4, 138.8, 129.0, 126.2 (2C), 121.7, 121.5, 117.1, 111.9, 111.0, 109.6, 88.6, 56.1, 56.0, 15.0; 
HRMS calcd. for C22H19N5O2 [M+] 385.1539, found. 385.1557. 
6-amino-3-methyl-4-(4-nitrophenyl)-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile 
(1c): 
Isolated as pale yellow solid, (333 mg, 90%), Rf: 0.60, Melting point: 223 – 225 °C; FT-IR: υ 
(cm-1) = 3350, 3208, 2214, 1619, 1581, 1348, 769; 1H NMR (300 MHz) δ 8.53 – 8.34 (m, 2H), 
8.10 (d, J = 7.7 Hz, 2H), 7.79 – 7.59 (m, 2H), 7.51 (t, J = 7.9 Hz, 2), 7.33 (t, J = 7.4 Hz, 1H), 
5.47 (br. s, 2H), 2.03 (s, 3H). 13C NMR (101 MHz) δ 158.1, 150.8, 149.7, 148.8, 143.6, 140.4, 
138.5, 129.9, 129.0, 126.4, 124.0, 121.5, 116.1, 109.0, 88.0, 14.8; HRMS calcd. for C20H14N6O2 
[M+] 370.1178, found. 370.1187. 
6-amino-4-(4-chlorophenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile 
(1d): 
Isolated as white solid, (327 mg, 91%), Rf: 0.74, Melting point: 194 – 198  °C; FT-IR: υ (cm-1) = 
3308, 3187, 2214, 1633, 824; 1H NMR (300 MHz) δ 8.10 (dd, J = 8.5, 1.0 Hz, 2H), 7.61 – 7.45 
(m, 4H), 7.45 – 7.38 (m, 2H), 7.31 (t, J = 7.4 Hz, 1H), 5.43 (br. s, 12H), 2.06 (s, 3H). 13C NMR 
(101 MHz) δ 158.3, 151.3, 150.9, 144.1, 138.7, 136.3, 132.4, 130.0, 129.0 (2C), 126.3, 121.5, 
116.6, 109.4, 88.4, 14.8; HRMS calcd. for C20H14ClN6 [M+] 359.0938, found. 370.0951. 
6-amino-4-(4-bromophenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile 
(1e):  
Isolated as white solid, (372 mg, 92%), Rf: 0.77, Melting point: 216 – 217 °C; FT-IR: υ (cm-1) = 
3369, 2920, 2217, 1637, 760;  1H NMR (300 MHz) δ 8.10 (dd, J = 8.6, 1.1 Hz, 2H), 7.75 – 7.67 
(m, 2H), 7.54 – 7.45 (m, 2H), 7.38 – 7.28 (m, 3H), 5.43 (br. s, 2H), 2.06 (s, 3H). 13C NMR (101 
MHz) δ 158.3, 151.3, 150.9, 144.1, 138.7, 132.8, 132.0, 130.2, 129.0, 126.3, 124.5, 121.5, 116.6, 
109.3, 88.3, 14.8; HRMS calcd. for C20H14BrN5 [M+] 403.0433, found. 403.0437. 
6-amino-4-(4-isopropylphenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-
carbonitrile (1f):  
Isolated as white solid, (320 mg, 87%), Rf: 0.71, Melting point: 198 – 200  °C; FT-IR: υ (cm-1) = 
3308, 3190, 2211, 1635, 709; 1H NMR (300 MHz) δ 8.11 (dd, J = 8.6, 1.1 Hz, 12H), 7.53 – 7.45 
(m, 2H), 7.40 (br. s, 4H), 7.34 – 7.27 (m, 1H), 5.42 (br. s, 2H), 3.10 – 2.93 (m, 1H), 2.06 (s, 3H), 
1.34 (s, 3H), 1.32 (s, 3H). 13C NMR (101 MHz) δ 158.4, 153.1, 150.9, 144.657, 138.8, 131.2, 
129.0, 128.7, 126.6, 126.1, 121.5, 117.1, 109.6, 88.5, 34.0, 23.9, 14.8; HRMS calcd. for 
C23H21N5 [M+] 367.1797, found. 367.1812. 
6-amino-4-(2,4-dichlorophenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-
carbonitrile (1g):  
Isolated as white solid, (359 mg, 91%), Rf: 0.82, Melting point: 167 – 169 °C; FT-IR: υ (cm-1) = 
3350, 3213, 2214, 1614, 757; 1H NMR (300 MHz) δ 8.11 (dd, J = 8.7, 1.1 Hz, 2H), 7.63 (d, J = 
2.0 Hz, 1H), 7.55 – 7.42 (m, 3H), 7.35 – 7.27 (m, 2H), 5.45 (br. s, 2H), 2.02 (s, 3H). 13C NMR 
(101 MHz) δ 158.2, 150.8, 148.2, 144.1, 138.7, 136.7, 133.5, 131.7, 130.8, 130.1, 129.0, 127.7, 
126.3, 121.5, 115.9, 109.6, 88.8, 13.5; HRMS calcd. for C20H13Cl2N5 [M+] 393.0548, found. 
393.0564. 
6-amino-3-methyl-1-phenyl-4-(p-tolyl)-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile (1h):  
Isolated as white solid, (315 mg, 93%), Rf: 0.72, Melting point: 200 – 202 °C; FT-IR: υ (cm-1) = 
3325, 3216, 2211, 1629, 762; 1H NMR (300 MHz) δ 8.16 – 8.07 (m, 2H), 7.54 – 7.44 (m, 2H), 
7.36 (br. s, 4H), 7.33 – 7.27 (m, 1H), 5.39 (br. s, 2H), 2.47 (s, 3H), 2.07 (s, 3H). 13C NMR (101 
MHz) δ 158.4, 153.1, 150.9, 144.5, 140.0, 138.8, 131.0, 129.3, 129.0, 128.5, 126.2, 121.6, 117.0, 
109.5, 88.5, 21.5, 14.8; HRMS calcd. for C21H17N5 [M+] 339.1484, found. 339.1495. 
6-amino-4-(4-fluorophenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile 
(1i):  
Isolated as white solid, (302 mg, 88%), Rf: 0.61, Melting point: 214 – 216 °C; FT-IR: υ (cm-1) = 
3328, 3222, 2214, 1629, 768; 1H NMR (300 MHz) δ 8.16 – 8.02 (m, 2H), 7.56 – 7.41 (m, 4H), 
7.39 – 7.16 (m, 3H, 1H CDCl3), 5.43 (br. s, 2H), 2.06 (s, 3H). 13C NMR (101 MHz) δ 163.6 (d, J 
= 250.4 Hz), 158.3, 151.6, 150.9, 144.2, 138.7, 130.6 (d, J = 8.5 Hz), 129.9 (d, J = 3.3 Hz), 
129.0, 126.3, 121.5, 116.7, 115.9 (d, J = 22.0 Hz), 109.5, 88.5, 14.8. 19F NMR (282 MHz) δ -
110.51; HRMS calcd. for C20H14FN5 [M+] 343.1233, found. 343.1244. 
6-amino-3-methyl-4-(3-nitrophenyl)-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile 
(1j):  
Isolated as white solid, (315 mg, 85%), Rf: 0.52, Melting point: 157 – 159 °C; FT-IR: υ (cm-1) = 
3357, 3224, 2216, 1617, 753; 1H NMR (400 MHz) δ 8.46 (m, 1H), 8.38 (t, J = 1.8 Hz, 1H), 8.19 
– 8.02 (m, 2H), 7.89 – 7.77 (m, 2H), 7.58 – 7.46 (m, 2H), 7.34 (m, 1H), 5.55 (br. s, 2H), 2.04 (s, 
3H). 13C NMR (75 MHz) δ 158.2, 149.4, 148.1, 143.6, 138.5, 138.1, 135.6, 134.5, 130.0, 129.0, 
126.5, 124.8, 123.9, 122.8, 121.6, 116.2, 88.2, 14.8; HRMS calcd. for C20H14N6O2 [M+] 
370.1178, found. 393.1195. 
6-amino-4-(4-methoxyphenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-
carbonitrile (1k):  
Isolated as white solid, (323 mg, 91%), Rf: 0.47, Melting point: 195 – 197 °C; FT-IR: υ (cm-1) = 
3353, 3224, 2216, 1629, 765 ; 1H NMR (400 MHz) δ 8.17 – 8.04 (m, 2H), 7.52 – 7.46 (m, 2H), 
7.44 – 7.39 (m, 2H), 7.33 – 7.27 (m, 1H), 7.09 – 7.05 (m, 2H), 5.40 (br. s, 2H), 3.90 (s, 3H), 2.10 
(s, 3H). 13C NMR (101 MHz) δ 160.9, 158.4, 152.8 , 151.0, 144.5, 138.8, 130.2, 129.0, 126.1 
(2C), 121.5, 117.2, 114.0, 109.7, 88.5, 55.4, 15.0. 
6-amino-4-(2,6-difluorophenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-
carbonitrile (1l):  
Isolated as white solid, (307 mg, 85%), Rf: 0.55, Melting point: 227 – 229 °C; FT-IR: υ (cm-1) = 
3318, 3202, 2213, 1630, 768;  1H NMR (300 MHz) δ 8.17 – 8.04 (m, 2H), 7.62 – 7.45 (m, 3H), 
7.36 – 7.27 (m, 1H), 7.19 – 7.10 (m, 2H), 5.43 (br. s, 2H), 2.11 (s, 3H). 13C NMR (101 MHz) δ 
159.54 (dd, J = 252.0, 6.0 Hz), 158.2, 150.9, 143.9, 139.7, 138.6, 132.4 (t, J = 10.0 Hz), 129.0, 
126.3, 121.6, 116.0, 112.0 (dd, J = 19.5, 6.0 Hz), 111.3 (t, J = 20.0 Hz), 110.0, 89.9, 13.0. 19F 
NMR (282 MHz) δ  -111.00; HRMS calcd. for C20H13F2N5 [M+] 361.1139, found. 361.1151. 
6-amino-3-methyl-4-(naphthalen-1-yl)-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile 
(1m):  
Isolated as white solid, (319 mg, 85%), Rf: 0.55, Melting point: 195 – 197 °C; FT-IR: υ (cm-1) = 
3385, 3319, 2210, 1621, 776; 1H NMR (300 MHz) δ 8.19 – 8.11 (m, 2H), 8.07 – 7.95 (m, 2H), 
7.64 (dd, J = 8.2, 7.1 Hz, 1H), 7.59 – 7.43 (m, 26H), 7.36 – 7.28 (m, 1H), 5.47 (br. s, 2H), 1.59 
(s, 3H). 13C NMR (101 MHz) δ 158.5, 151.5, 150.7, 144.7, 138.8, 133.4, 131.6, 131.0, 130.2, 
129.0, 128.6, 127.3, 126.6 (2C), 126.2, 125.2, 124.8, 121.5, 116.5, 110.8, 89.7, 13.4; HRMS 
calcd. for C24H17N5 [M+] 375.1484, found. 375.1503. 
6-amino-3-methyl-4-(naphthalen-2-yl)-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile 
(1n):  
Isolated as white solid, (338 mg, 90%), Rf: 0.58, Melting point: 270 – 272 °C; FT-IR: υ (cm-1) = 
3356, 3219, 2217, 1623, 744;  1H NMR (300 MHz) δ 8.19 – 8.06 (m, 12H), 8.03 (d, J = 8.5 Hz, 
1H), 7.99 – 7.92 (m, 3H), 7.66 – 7.47 (m, 5H), 7.35 – 7.27 (m, 1H), 5.45 (br. s, 2H), 2.02 (s, 
31H). 13C NMR (101 MHz) δ 158.4, 152.7, 150.9, 144.5, 138.8, 133.7, 132.7, 131.4, 129.0, 
128.5 (2C), 128.0, 127.4, 127.0, 126.2, 125.7, 121.6, 116.9, 109.7, 88.7, 14.8; HRMS calcd. for 
C24H17N5 [M+] 375.1484, found. 375.1501. 
6-amino-4-(3,5-difluorophenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-
carbonitrile (1o):  
Isolated as white solid, (314 mg, 87%), Rf: 0.67, Melting point: 198 – 200 °C; FT-IR: υ (cm-1) = 
3348, 3227, 2219, 1632, 744; 1H NMR (300 MHz) δ 8.17 – 8.06 (m, 2H), 7.57 – 7.48 (m, 2H), 
7.37 – 7.30 (m, 1H), 7.12 – 6.97 (m, 3H), 5.47 (br. s, 2H), 2.10 (s, 3H). 13C NMR (126 MHz) δ 
162.89 (dd, J = 252.0, 13.0 Hz), 158.2, 150.8, 149.6, 143.8, 138.6, 136.9 (t, J = 10.0 Hz), 129.0, 
126.4, 121.5, 116.1, 112.1 (dd, J = 20.0, 7.0 Hz), 109.1, 105.5 (t, J = 25.0 Hz), 88.1, 14.5; 19F 
NMR (376 MHz) δ -107.5; HRMS calcd. for C20H13F2N5 [M+] 361.1139, found. 361.1150. 
6-amino-4-(3,4-difluorophenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-
carbonitrile (1p):  
Isolated as white solid, (322 mg, 89%), Rf: 0.57, Melting point: 203 – 205 °C; FT-IR: υ (cm-1) = 
3369, 3227, 2215, 1634, 764; 1H NMR (300 MHz) δ 8.15 – 8.08 (m, 2H), 7.56 – 7.48 (m, 2H), 
7.43 – 7.30 (m, 3H), 7.27 – 7.21 (m, 1H), 5.46 (br. s, 2H), 2.10 (s, 3H). 13C NMR (126 MHz) δ 
158.2, 151.4 (dd, J = 252.6, 12.2 Hz), 150. 9, 150.24 (dd, J = 251.6, 12.8 Hz), 150.0 (d, J = 0.9 
Hz), 143.8, 138.6, 130.7 (dd, J = 6.0, 4.3 Hz), 129.0, 126.3, 125.2 (dd, J = 6.6, 4.0 Hz), 121.5, 
118.1 (dd, J = 25.0, 18.0 Hz), 116.3, 109.3, 88.4, 14.7; 19F NMR (376 MHz) δ -135.15 (dd, J = 
311.5, 21.3 Hz); HRMS calcd. for C20H13F2N5 [M+] 361.1139, found. 361.1152. 
6-amino-4-(4-cyanophenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile 
(1q):  
Isolated as white solid, (326 mg, 93%), Rf: 0.50, Melting point: 237 – 239 °C; FT-IR: υ (cm-1) = 
3338, 3216, 2228, 2211, 1619; 1H NMR (300 MHz) δ 8.13 – 8.06 (m, 2), 7.93 – 7.85 (m, 2H), 
7.65 – 7.58 (m, 2H), 7.55 – 7.47 (m, 2H), 7.36 – 7.29 (m, 1H), 5.47 (br. s, 2H), 2.02 (s, 3H). 13C 
NMR (126 MHz) δ 158.2, 150.9, 150.0, 143.6, 138.6, 132.5, 129.5, 129.0, 126.4, 121.5, 117.9, 
116.2, 114.1, 109.0, 88.0, 14.7; HRMS calcd. for C21H14N6 [M+] 350.1280, found. 350.1303. 
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 ﻪﺟﻭﺗﻣ ﺍﺭ ﺱﻧﺭﻓﺭ ﻥﻳﺍ ﻥﺩﺷ ﺕﻳﻼﻳﺎﻫ ﺕﻠﻋ
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